Little known short-seller Jehoshaphat Research has targeted TTI. Most allegations are difficult to refute. Our analysis reveals there is considerable evidence to believe numbers are not true and fair
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.